Trials / Available
AvailableNCT07218224
Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Thomas Hope · Academic / Other
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- —
Summary
This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.
Detailed description
No health outcome measures will be obtained under this protocol.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 18F-Fluorocholine (FCH) | A dose of 4-7 millicurie (mCi) +/- 10% of radiotracer 18F-Fluorocholine (FCH) manufactured at UCSF will be given intravenously. |
| PROCEDURE | Positron emission tomography (PET) | A scan is a procedure that produces images of organs and tissues used in conjunction with a radiotracer. |
Timeline
- First posted
- 2025-10-20
- Last updated
- 2025-10-20
Source: ClinicalTrials.gov record NCT07218224. Inclusion in this directory is not an endorsement.